RxDoctor Payments Data

Gurleen Brar, DPM

Podiatrist · Lithonia, GANPI 1154818235

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (49.2%), travel and lodging and education — rather than concentrated in one kind of arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 16.6%. Reporting peaked in 2023 at $2,123 and has fallen 70.1% since, to $635 in 2025.

$7,247in general payments, 2019–2025

Across 93 payments — averaging $77.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medwest Associates$1K
  • Triad Life Sciences Inc.$1K
  • Arthrex$1K
  • United Orthopedics LLC$637
  • Kerecis Limited$575
  • Stryker$422
  • plus $2K from 28 others

What the payments were for

  • Travel & lodging$2,48034%
  • Food & beverage$3,56749%
  • Education$1,20017%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,247 in reported general payments places this provider in the 80th percentile of 177 podiatrist providers in Georgia.

See all podiatrist providers in Georgia

Medicare billing

Part B allowed, 2024
$74,658
Medicare patients
230
Services billed
915

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox100$2,621
Ammonium Lactate44$792
Clotrimazole53$665
Ketoconazole21$409
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip14$166

Paid to pharmacies, not to this prescriber.

Other podiatrist in Lithonia

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →